HOME >> BIOLOGY >> NEWS
Cutting The Time And Cost Of Developing New Cures: Lord Sainsbury Launches World's First Biomedical Accelerator Mass Spectrometer In York

The first Accelerator Mass Spectrometer (AMS) in the world to be dedicated to biomedical research is launched officially today (23 November) by Lord Sainsbury, the Minister for Science at CBAMS Ltd.

Identifying promising drugs that could lead to life saving cures in the future can take eight to ten years and cost as much as 200 million. The AMS can investigate large numbers of drugs for pharmaceutical companies, significantly speeding up drug development by quickly identifying the most promising. In some cases it may cut development time by up to six months. With new drugs earning 1 million per day the appeal of using the AMS is obvious. The technique, which is based on carbon dating used to measure the age of ancient finds, will be between one hundred thousand and one million times more sensitive than traditional methods.

"For the first time, pharmaceutical and other biomedical research companies all over the world can access a technique which will speed up drug investigations significantly," said Professor Colin Garner, chief executive officer of CBAMS Ltd. "The technique will also make such investigations safer."

Lord Sainsbury said: "This initiative is a landmark for UK science and reinforces York's position as an important centre for scientific expertise, with a reputation for excellence, initiative and endeavour that is admired internationally."

The AMS is located at the Central Science Laboratory at Sand Hutton, York, and is operated by CBAMS Ltd (the Centre for Biomedical Accelerator Mass Spectrometry), a subsidiary company of the University of York. The machine was purchased with guaranteed contracts for research projects from Glaxo Wellcome, Pfizer, Novartis and Janssen Pharmaceutica.

"CBAMS is a prime example of the sort of start-up company which will be encouraged under the Science City York project," commented Professor Ron Cooke, Vice-Chancellor of the University of York. "CBAMS has worked closely with potential customers
'"/>

Contact: Professor Colin Garner
colin.garner@cbams.co.uk
44-1904-462700
University of York
20-Nov-1998


Page: 1 2

Related biology news :

1. Cutting-edge cancer researchers sought for international recognition
2. Cutting back on cigarettes: when less is more
3. AChemS: Cutting edge research in taste, smell, & chemical irritation
4. Cutting edge
5. Cutting-edge research to be presented at ASCPT pharmacology conference
6. Cutting the risk of coronary disease - start before birth says UK doctor
7. Story Tips: Engineering Students Pursue Cutting-Edge Research
8. Brain Building May Depend On DNA Cutting And Pasting
9. Flexibility In Cutting Toxic Releases Yields Dividends
10. Gene Shears In Cutting Edge Anti-Aids Trial
11. Developing tools for reliable gene chip measurements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/5/2020)... ... March 05, 2020 , ... Patients in need of new teeth after ... Nickelice Brand of Dental Implants of Ocala. Same-day dental implants allow patients ... smile in just one day. This treatment utilizes advanced technology and Dr. Brand’s unique ...
(Date:3/5/2020)... BOSTON (PRWEB) , ... March 05, 2020 , ... ... its AlphaSTEM Test™ technology . The AlphaSTEM Test™ is the first, ... tissue stem cells. Other technologies that attempt to provide information about the ...
(Date:3/4/2020)... BOSTON (PRWEB) , ... March 04, 2020 , ... ... startup founders and CEOs to apply to the MedTech IGNITE program’s 2020 IGNITE ... mentorship and networking curriculum to attract and nurture the next generation of medtech ...
Breaking Biology News(10 mins):
(Date:3/19/2020)... ... March 17, 2020 , ... ... gene circuit company Senti Biosciences, Inc. (Senti) to accelerate the clinical translation ... indications. The collaboration will leverage RoosterBio’s human mesenchymal stem/stromal cell (hMSC) bioprocess ...
(Date:3/13/2020)... ... March 12, 2020 , ... Today, DuPont Nutrition & ... Center (APC), a pioneer in the field of microbiome science, which focuses on ... in human health, based at University College Cork and Teagasc Moorepark. , Representatives ...
(Date:3/10/2020)... (PRWEB) , ... March 10, 2020 , ... Ortho Clinical ... through innovative laboratory solutions, announced its ORTHOTM Sera, ID-MTS, a suite of extended antigen ... transfusion, is cleared to run on ORTHO VISION® and ORTHO VISION® Max in the ...
(Date:3/10/2020)... Texas (PRWEB) , ... March 10, 2020 , ... ... facility on 13 acres in Cleburne, Texas to be used as a biopharmaceutical and ... its global headquarters and sales offices as well as its production and development hub. ...
Breaking Biology Technology:
Cached News: